Client: Prevtec Microbia West Canada Inc.

 

Project Title: Development of a Live Oral Combination Vaccine for the Prevention of Infections in Pigs Caused by F4 and F18 E.coli Strains

 

Description: Prevtec is proposing to develop a F4/F18 combination oral vaccine which is effective in controlled challenge trials to reduce intestinal colonization, fecal excretion and clinical signs associated with F4-positive and F18-positve pathogenic E. coli strains and is safe in field safety studies.

 

ACS CAAP Funding: $99,000.00

 

Project Cost: $525,000.00

 

<<Return to projects funded from April 1, 2010 to June 30, 2010

 

<<Return to funded projects page